AR003977A1 - Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion. - Google Patents

Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion.

Info

Publication number
AR003977A1
AR003977A1 ARP960103941A AR10394196A AR003977A1 AR 003977 A1 AR003977 A1 AR 003977A1 AR P960103941 A ARP960103941 A AR P960103941A AR 10394196 A AR10394196 A AR 10394196A AR 003977 A1 AR003977 A1 AR 003977A1
Authority
AR
Argentina
Prior art keywords
didepsipeptides
production
new
endoparastic
procedures
Prior art date
Application number
ARP960103941A
Other languages
English (en)
Original Assignee
Markiewikz Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Markiewikz Mario filed Critical Markiewikz Mario
Publication of AR003977A1 publication Critical patent/AR003977A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/58—Y being a hetero atom
    • C07C275/62—Y being a nitrogen atom, e.g. biuret
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/50—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invención se refiere al uso de didepsipétidos de fórmula general (I) y de sus sales, en la cual los radicales tienen el significadoindicado en la memoria descriptiva, así como a nuevos didepsipéptidos y procedimientos parasu producción.
ARP960103941A 1995-08-11 1996-08-09 Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion. AR003977A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19529604A DE19529604A1 (de) 1995-08-11 1995-08-11 Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
AR003977A1 true AR003977A1 (es) 1998-09-30

Family

ID=7769288

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103941A AR003977A1 (es) 1995-08-11 1996-08-09 Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion.

Country Status (26)

Country Link
US (2) US20020142969A1 (es)
EP (1) EP0843658B1 (es)
JP (3) JPH11511142A (es)
KR (1) KR19990036304A (es)
CN (2) CN1053657C (es)
AR (1) AR003977A1 (es)
AT (1) ATE229933T1 (es)
AU (1) AU707123B2 (es)
BG (1) BG64091B1 (es)
BR (1) BRPI9610049B1 (es)
CA (1) CA2228939C (es)
CZ (1) CZ41698A3 (es)
DE (2) DE19529604A1 (es)
DK (1) DK0843658T3 (es)
ES (1) ES2190476T3 (es)
HK (1) HK1017340A1 (es)
HU (1) HUP9802316A3 (es)
MX (1) MX9801133A (es)
NO (1) NO311566B1 (es)
NZ (1) NZ315642A (es)
PL (1) PL187412B1 (es)
SK (1) SK15598A3 (es)
TR (1) TR199800210T2 (es)
TW (1) TW492976B (es)
WO (1) WO1997007093A1 (es)
ZA (1) ZA966749B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
WO2007070425A2 (en) 2005-12-09 2007-06-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of low-dose ladostigil for neuroprotection
TW200744576A (en) 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
WO2009070631A2 (en) * 2007-11-28 2009-06-04 University Of Virginia Patent Foundation Ethoid compounds for use as food additives
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) * 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619247C2 (de) * 1976-04-30 1986-04-03 Eckert, Heiner, Dipl.-Chem. Dr., 8000 München Verfahren zum Schutze reaktionsfähiger Amino-, Hydroxyl- und/oder Carboxylgruppen
FR2365341A1 (fr) * 1976-09-28 1978-04-21 Synthelabo Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
HU181008B (en) * 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
JPS606649A (ja) * 1983-06-24 1985-01-14 Daicel Chem Ind Ltd モノマ−
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
PT634408E (pt) * 1992-03-17 2002-05-31 Fujisawa Pharmaceutical Co Derivado de depsipeptido sua producao e utilizacao
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
WO1994019334A1 (en) * 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4341991A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Hexadepsipeptiden
DE4341992A1 (de) * 1993-12-09 1995-06-14 Bayer Ag Endoparasitizide Mittel auf Basis von offenkettigen Tetradepsipeptiden

Also Published As

Publication number Publication date
BG102213A (en) 1998-08-31
EP0843658A1 (de) 1998-05-27
JP2010222361A (ja) 2010-10-07
BRPI9610049B1 (pt) 2017-05-02
HUP9802316A3 (en) 2001-04-28
HK1017340A1 (en) 1999-11-19
NZ315642A (en) 2000-01-28
CN1254596A (zh) 2000-05-31
SK15598A3 (en) 1998-09-09
CZ41698A3 (cs) 1998-06-17
CA2228939A1 (en) 1997-02-27
ATE229933T1 (de) 2003-01-15
TW492976B (en) 2002-07-01
US7772190B2 (en) 2010-08-10
CN1199394A (zh) 1998-11-18
ES2190476T3 (es) 2003-08-01
BR9610049A (pt) 1999-07-06
KR19990036304A (ko) 1999-05-25
WO1997007093A1 (de) 1997-02-27
MX9801133A (es) 1998-05-31
CA2228939C (en) 2007-01-30
DE59610011D1 (de) 2003-01-30
BG64091B1 (bg) 2003-12-31
NO980324D0 (no) 1998-01-26
US20040034048A1 (en) 2004-02-19
NO311566B1 (no) 2001-12-10
JPH11511142A (ja) 1999-09-28
EP0843658B1 (de) 2002-12-18
TR199800210T2 (xx) 1998-08-21
DK0843658T3 (da) 2003-04-14
AU707123B2 (en) 1999-07-01
JP2014159449A (ja) 2014-09-04
DE19529604A1 (de) 1997-02-13
PL324893A1 (en) 1998-06-22
ZA966749B (en) 1997-02-18
NO980324L (no) 1998-03-05
HUP9802316A2 (hu) 1999-02-01
US20020142969A1 (en) 2002-10-03
AU6739496A (en) 1997-03-12
PL187412B1 (pl) 2004-07-30
CN1053657C (zh) 2000-06-21

Similar Documents

Publication Publication Date Title
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
ECSP045347A (es) "derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso"
PA8577001A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
UY26958A1 (es) Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
ES2148503T3 (es) Derivados de 3-aril-4-hidroxi-delta3-dihidrotiofenona.
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
ES2192213T3 (es) Arilalquil-diazinonas como inhibidores de fosfodiesterasa iv.
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
CR8360A (es) 1,3 dimetilbutilcarboxanilidas
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
CU23415B7 (es) Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos
UY27244A1 (es) Uso del acido- (4´-trifluormetilfenil) - amida (z) -2- ciano-3- hidroxi-but-2-enoico para el tratamiento de la esclerosis multiple
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
UY29221A1 (es) Derivados de octahidropirrolo(3,4-c)pirrol
NO20034667L (no) Arylsulfonamider som antivirale midler
AR003977A1 (es) Composiciones endoparasiticidas a base de didepsipeptidos, nuevos didepsipeptidos y procedimientos para su produccion.
PA8589801A1 (es) Aminoalcoxiindoles
PA8542201A1 (es) Inhibidores de pcp basados en acidos-3-heterociclilpropanohidroxamicos
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger

Legal Events

Date Code Title Description
FA Abandonment or withdrawal